Ercros (ECR)

Madrid
Currency in EUR
3.540
+0.015(+0.57%)
Closed
ECR Scorecard
Full Analysis
Stock generally trades with low price volatility
Fair Value
Day's Range
3.5253.540
52 wk Range
2.2603.980
Key Statistics
Edit
Bid/Ask
3.525 / 3.545
Prev. Close
3.525
Open
3.53
Day's Range
3.525-3.54
52 wk Range
2.26-3.98
Volume
29.73K
Average Volume (3m)
46.97K
1-Year Change
41.6%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ECR Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to drop this year
Show more

Ercros Company Profile

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers and polychloride. This segment’s products are used as intermediates in other industrial processes to purify and treat drinking and waste water; treat and maintain swimming pool water; bleach fabrics and paper; produce solvents, detergents, and strippers; manufacture printing inks and coloring; to produce compound feed and in cooling equipment. The Intermediate Chemicals segment provides formaldehyde, glues and resins, molding compunds, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing of particle, and decorative laminates and plywoods, as well as resins, paints, and varnishes in the furniture and decoration industry; sockets and switches in the electrical components sector; and tableware, and health and packaging items in the textile tanning industry. The Pharmacy division engages in the production of raw materials and pharmaceutical intermediate products from antibiotic, cholesterol-lowering, anti-ulcer, and anti-fungal agents. This segment’s products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, fosfomycin calcium and sodium, fosfomycin trometamol, and fusidic acid. The company is also involved in exporting activities. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.

Industry
Chemicals
Employees
1253
Market
Spain

Compare ECR to Peers and Sector

Metrics to compare
ECR
Peers
Sector
Relationship
P/E Ratio
22.9x−4.2x−0.1x
PEG Ratio
-−0.520.00
Price/Book
0.9x0.9x1.6x
Price / LTM Sales
0.5x0.6x1.2x
Upside (Analyst Target)
28.5%37.0%30.2%
Fair Value Upside
Unlock17.2%2.9%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.137
Dividend Yield
2.20%
Industry Median 0.70%
Annualised payout
0.0778
Paid annually
5-Years Growth
+9.86%
Growth Streak

Earnings

Latest Release
Nov 06, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

People Also Watch

13.720
TRE
0.00%
3.140
DOMI
+0.64%
0.386
OHLA
0.00%
18.63
PUIGb
+0.22%
34.150
GREG
+1.64%

FAQ

What Is the Ercros (ECR) Stock Price Today?

The Ercros stock price today is 3.54

What Stock Exchange Does Ercros Trade On?

Ercros is listed and trades on the Madrid stock exchange.

What Is the Stock Symbol for Ercros?

The stock symbol for Ercros is "ECR."

Does Ercros Pay Dividends? What’s The Current Dividend Yield?

The Ercros dividend yield is 2.20%.

What Is the Ercros Market Cap?

As of today, Ercros market cap is 323.68M.

What is Ercros Earnings Per Share?

The Ercros EPS is 0.137.

What Is the Next Ercros Earnings Date?

Ercros will release its next earnings report on 27 Feb 2025.

From a Technical Analysis Perspective, Is ECR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.